ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis.
Yuxiang QiuXing WangYan SunTing JinRui TangXinyue ZhouMing XuYubi GanRui WangHaojun LuoManran LiuXi TangPublished in: Cancer research (2024)
ACSL4 upregulation in triple-negative breast cancer alters cell membrane phospholipid composition to increase integrin β1 activation and drive metastasis, indicating that targeting ACSL4 could potentially block metastasis and improve patient outcomes.